D L Morton Selected Research

Canvaxin

1/2004

Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D L Morton Research Topics

Disease

28	Melanoma (Melanoma, Malignant) 08/2009 - 01/2000
24	Neoplasms (Cancer) 08/2009 - 01/2000
5	Neoplasm Micrometastasis 10/2001 - 03/2000
5	Neoplasm Metastasis (Metastasis) 08/2001 - 04/2000
2	Hypersensitivity (Allergy) 01/2004 - 06/2001
2	Carcinoma (Carcinomatosis) 05/2002 - 09/2000
2	Colonic Neoplasms (Colon Cancer) 06/2001 - 06/2000
1	Disease Progression 01/2004
1	Polyps 07/2001
1	Paralysis (Palsy) 06/2001
1	Colorectal Neoplasms (Colorectal Cancer) 03/2001
1	Breast Neoplasms (Breast Cancer) 02/2001
1	Lymphatic Metastasis 07/2000
1	Thrombocytopenia (Thrombopenia) 06/2000
1	Liver Neoplasms (Liver Cancer) 06/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2000
1	Adenocarcinoma 04/2000
1	Necrosis 04/2000
1	Lung Neoplasms (Lung Cancer) 01/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2000

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2004 - 04/2000
6	VaccinesIBA 01/2004 - 04/2000
6	Coloring Agents (Dyes)IBA 05/2002 - 08/2000
4	polyvalent melanoma cell vaccineIBA 01/2004 - 04/2001
4	Immunoglobulin M (IgM)IBA 01/2004 - 04/2000
3	Keratins (Keratin)IBA 07/2001 - 11/2000
2	Glycoproteins (Glycoprotein)IBA 01/2004 - 04/2001
2	AntibodiesIBA 01/2004 - 04/2000
2	CarbonIBA 08/2001 - 07/2001
2	Cell-Free Nucleic AcidsIBA 08/2001 - 04/2000
2	Genetic Markers (Genetic Marker)IBA 08/2001 - 04/2001
2	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 07/2001 - 08/2000
2	Immunoglobulins (Immunoglobulin)IBA 06/2001 - 04/2000
2	Biomarkers (Surrogate Marker)IBA 04/2001 - 04/2000
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2001 - 02/2001
2	ImmunosorbentsIBA 02/2001 - 04/2000
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2001 - 04/2000
2	EnzymesIBA 02/2001 - 04/2000
2	Carcinoembryonic AntigenIBA 09/2000 - 06/2000
2	GangliosidesIBA 04/2000 - 04/2000
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 08/2009
1	Immunoglobulin G (IgG)IBA 01/2004
1	CanvaxinIBA 01/2004
1	Cancer VaccinesIBA 01/2004
1	Oxidoreductases (Dehydrogenase)IBA 08/2001
1	chinese inkIBA 07/2001
1	Proteins (Proteins, Gene)FDA Link 06/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2001
1	Melanoma-Specific AntigensIBA 06/2001
1	Tuberculin (PPD)IBA 06/2001
1	CytokinesIBA 06/2001
1	ParaffinIBA 04/2001
1	DNA (Deoxyribonucleic Acid)IBA 04/2001
1	TA90 immune complexIBA 02/2001
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 02/2001
1	Proto-Oncogene Proteins c-metIBA 02/2001
1	RNA (Ribonucleic Acid)IBA 02/2001
1	Tumor Biomarkers (Tumor Markers)IBA 01/2001
1	Monoclonal AntibodiesIBA 09/2000
1	CarbohydratesIBA 09/2000
1	SuspensionsIBA 04/2000
1	Dihydrotachysterol (AT 10)IBA 03/2000
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2000
1	Interleukin Receptor Common gamma SubunitIBA 01/2000
1	Interleukin-4 (Interleukin 4)IBA 01/2000
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2000
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2000
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2000
1	RadiopharmaceuticalsIBA 01/2000

Therapy/Procedure

13	Lymph Node Excision (Lymph Node Dissection) 08/2004 - 01/2000
12	Therapeutics 01/2004 - 01/2000
4	Immunotherapy 10/2001 - 04/2000
2	Cytoreduction Surgical Procedures 01/2004 - 07/2001
2	Aftercare (After-Treatment) 04/2001 - 01/2000
2	Adjuvant Chemotherapy 03/2001 - 02/2001
1	Colonoscopes 07/2001
1	Colectomy 07/2001
1	Lasers (Laser) 04/2001
1	Radiotherapy 09/2000
1	Adjuvant Radiotherapy 09/2000
1	Length of Stay 06/2000
1	Radiofrequency Ablation 06/2000